Treatment of Acute Respiratory Syncytial Virus (RSV) Infection
A Phase 2 Randomized, Placebo-controlled Study of the Safety and Efficacy of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection. Experiencing a runny nose, cough, congestion, or wheezing? RSV might be the culprit, and a quick test can confirm. Take action, contact us today about a clinical trial, and help fight back against RSV. No Cost RSV testing. See if you qualify for a clinical trial. RSV can be a serious,
life-threatening virus for
high-risk adults who are 18
years or older and meet at
least 1 of the following criteria:
• Moderate or severe COPD
• Asthma
• Chronic lung disease
• Chronic cardiovascular disease
• ≥60 years of age (vaccinated or
nonvaccinated). Why join an RSV clinical trial?
• Access to an investigational
oral medication for RSV
• Limited treatment options for
high-risk adults
• No FDA-approved oral
treatment available
• Don’t have to discontinue
current medications to participate
» Study Details | Apply for the Study
|